Entact Bio Appoints Michael Gutch, Ph.D., as Chief Operating Officer
WATERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2024--
Stay updated with breaking news from Noema Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WATERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2024--
BASEL, Switzerland, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, today announced that members of management will attend and present at two upcoming conferences in San Francisco, CA. SACHS 7th Annual Neuroscience Innovation ForumFormat: Panel DiscussionTitle: Exploring New Modalities for Rare & Orphan Neurological DiseasesDate: Sunday, January 7, 2024 Time: 11:00 a.m. PST (2:00 p.m. EST/8:00 p.m. CE
Seeking participants for clinic trial.
The companies Wilson Wolf Corporation, Cargo Therapeutics and Noema Pharma bagged the biggest biotech investments in March 2023.
Company has raised $112m in order to develop therapies for central nervous system disorders - News - PharmaTimes